<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0004818'>Paroxysmal nocturnal hemoglobinuria</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e>) and <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> are associated either as a <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e>-<z:mpath ids='MPATH_58'>aplasia</z:mpath> syndrome or the emergence of <z:chebi fb="0" ids="24410">glycosylphosphatidylinositol</z:chebi>-(GPI)deficient blood cells in patients with severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (SAA) </plain></SENT>
<SENT sid="1" pm="."><plain>It could be demonstrated that SAA patients with GPI-deficient cells in comparison to those without have a worse response to classical immunosuppressive therapy </plain></SENT>
<SENT sid="2" pm="."><plain>Therefore, we treated a female <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> patient with severe <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, <z:hpo ids='HP_0001903'>anemia</z:hpo> and <z:e sem="disease" ids="C1306872,C0001824" disease_type="Disease or Syndrome;Laboratory or Test Result" abbrv="">granulopenia</z:e> with G-CSF and <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>Within 8 weeks, a trilineage response of hematopoiesis was observed </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, the proportion of <z:mpath ids='MPATH_458'>normal</z:mpath> to GPI-deficient granulocytes and monocytes increased significantly </plain></SENT>
</text></document>